8-K filing — Concentra Group Holdings Parent, Inc. (CON)
Filed: 2026-08-27 AccNo: 0002014596-26-000060 Size: 3 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Concentra Standout in Occupational Medicine: Analyst
William Blair initiated Concentra with an Outperform rating, citing strong earnings, higher guidance and leadership in occupational medicine.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wells Fargo Maintains Overweight on Concentra Group Holdings, Raises Price Target to $40
Wells Fargo analyst Stephen Baxter maintains Concentra Group Holdings (NYSE:CON) with a Overweight and raises the price target from $28 to $40.
Truist Securities Maintains Buy on Concentra Group Holdings, Raises Price Target to $42
Truist Securities analyst David Macdonald maintains Concentra Group Holdings (NYSE:CON) with a Buy and raises the price target from $37 to $42.
RBC Capital Maintains Outperform on Concentra Group Holdings, Raises Price Target to $42
RBC Capital analyst Ben Hendrix maintains Concentra Group Holdings (NYSE:CON) with a Outperform and raises the price target from $36 to $42.